Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lilly, UnitedHealth to Study Bamlanivimab in High-risk COVID-19

contractpharmaDecember 07, 2020

Tag: COVID-19 , Eli Lilly , Bamlanivimab , UnitedHealth Group

PharmaSources Customer Service